NanJing Pharmaceutical Co Ltd
SSE:600713
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
Total Assets
NanJing Pharmaceutical Co Ltd
Total Assets Peer Comparison
1099
601607
600998
000963
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Total Assets
¥28.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Assets
¥417.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Assets
¥212B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Assets
¥92.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Assets
¥32.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Assets
¥33.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Total Assets?
Total Assets
28.4B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Total Assets amounts to 28.4B CNY.
What is NanJing Pharmaceutical Co Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
10%
Over the last year, the Total Assets growth was -14%. The average annual Total Assets growth rates for NanJing Pharmaceutical Co Ltd have been 3% over the past three years , 5% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
